Clinical trials
Coronary Stenosis trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Completed | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China National Center for Cardiovascular Diseases | 3 |
| Abbott Medical Devices | 2 |
| CCRF Inc., Beijing, China | 2 |
| Capital Medical University | 1 |
| DK Medical Technology (Suzhou) Co., Ltd. | 1 |
| Duk-Woo Park, MD | 1 |
| Peking University First Hospital | 1 |
| Shanghai MicroPort Medical (Group) Co., Ltd. | 1 |
| Shanghai MicroPort Rhythm MedTech Co., Ltd. | 1 |
| Sino Medical Sciences Technology Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Stenosis | 15 |
| Coronary Artery Disease | 7 |
| Myocardial Ischemia | 3 |
| Coronary Restenosis | 2 |
| Angina, Stable | 1 |
| Angina, Unstable | 1 |
| Cardiovascular Diseases | 1 |
| Constriction, Pathologic | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.